Arvind Remedies Ltd - Stock Valuation and Financial Performance

BSE: 531823 | NSE: ARVINDREM | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Arvind Remedies

M-Cap below 100cr DeciZen not available

Arvind Remedies stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
32 Cr.
52-wk low:
4.7
52-wk high:
4.7

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Arvind Remedies:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15TTM
ROCE % 7.5%8.1%8.1%8.8%11.1%10.9%9.6%13.4%14%-34.6%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 14415717621829836343766491163012
Sales YoY Gr.-8.8%12.2%24%36.7%21.8%20.4%52.1%37.2%-30.9%-
Adj EPS 1.31.721.74.13.548.48.6-38.6-20.2
YoY Gr.-34.4%17.9%-15.7%144.3%-14.2%14.9%109%2.9%-546.3%-
BVPS (₹) 14.815.917.218.52225.228.135.439.9-5.8-23.6
Adj Net
Profit
3.34.45.24.410.616.919.440.558.9-263-137
Cash Flow from Ops. -8.610.116-13-7.712.1713.3-60.3-121-
Debt/CF from Ops. -6.68.45.4-8-15.915.25239.2-10.3-5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.8%16.2%13%-30.9%
Adj EPS -246.4%-256.7%-312.5%-546.3%
BVPS-190.2%-176.7%-159.2%-114.6%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15TTM
Return on
Equity %
8.711129.414.915.614.62424.9-277136.9
Op. Profit
Mgn %
7.68.69.19.110.511.415.520.119.4-5.5-780.2
Net Profit
Mgn %
2.32.82.923.64.74.46.16.5-41.7-1124.9
Debt to
Equity
1.52.11.92.22.21.52.73.12.3-15.1-
Working Cap
Days
1741831821921862252292112252707,047
Cash Conv.
Cycle
125138122123118124145131130212-4,492

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Arvind Remedies Ltd.

Standalone Consolidated
TTM EPS (₹) -20.2 8.6
TTM Sales (₹ Cr.) 12.2 963
BVPS (₹.) -23.6 40.5
Reserves (₹ Cr.) -229 208
P/BV -0.20 0.12
PE 0.00 0.55
From the Market
52 Week Low / High (₹) 4.70 / 4.70
All Time Low / High (₹) 3.78 / 110.00
Market Cap (₹ Cr.) 32
Equity (₹ Cr.) 68.1
Face Value (₹) 10
Industry PE 47.8

Management X-Ray of Arvind Remedies:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.0030.4536.8928.8655.7799.5999.5999.5999.5999.59
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Arvind Remedies

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15
Sales143.91156.59175.67217.89297.77362.55436.63664.26911.11787.07
Operating Expenses 133.27143.06159.70198.14266.56321.31368.84530.53734.17830.22
Manufacturing Costs11.5213.6214.0412.3416.7318.5819.9436.9463.405.80
Material Costs113.87121.18135.98175.86236.60287.92329.69465.61635.05788.27
Employee Cost 2.793.224.224.766.256.659.0813.4417.4115.99
Other Costs 5.095.045.465.176.988.1610.1314.5418.3020.17
Operating Profit 10.6313.5315.9719.7531.2141.2567.78133.73176.94-43.15
Operating Profit Margin (%) 7.4%8.6%9.1%9.1%10.5%11.4%15.5%20.1%19.4%-5.5%
Other Income 0.660.220.200.830.350.340.390.590.475.86
Interest 4.766.557.4811.4814.1816.3927.7259.1977.1071.07
Depreciation 1.511.701.801.942.112.433.2412.5913.9029.46
Exceptional Items 00000.080000-187.46
Profit Before Tax 5.025.496.897.1715.3422.7737.2162.5586.39-325.28
Tax 1.951.111.772.354.715.8717.8021.9327.50-5.24
Profit After Tax 3.074.385.134.8210.6416.9019.4140.6258.90-320.04
PAT Margin (%) 2.1%2.8%2.9%2.2%3.6%4.7%4.4%6.1%6.5%-40.7%
Adjusted EPS (₹)1.21.72.01.94.13.54.08.48.7-47.0
Dividend Payout Ratio (%)42%30%25%27%12%20%17%12%9%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15

Equity and Liabilities

Shareholders Fund 38.3641.2244.8348.1257.24121.61143.09178.10279.47-42.28
Share Capital 26.0126.0126.0126.0126.0148.2348.2348.2368.1368.13
Reserves 12.3515.2118.8222.1131.2373.3894.86129.87211.34-110.41
Minority Interest0000000000
Debt56.8784.9386.39103.72122.99180.33342.48495.27573.89663.01
Long Term Debt56.8784.9386.39103.72122.9979.44188.19278.63244.54193.75
Short Term Debt00000100.88154.30216.64329.35469.25
Trade Payables7.7817.3628.2425.8133.2540.8238.5066.6294.498.15
Others Liabilities 13.9514.0314.1214.6154.5027.1678.76101.77143.74154.89
Total Liabilities 116.97157.54173.57192.26267.98369.93602.83841.761,091.59783.76

Fixed Assets

Gross Block32.1635.3838.8244.7248.0257.98258.07277.80390.11347.30
Accumulated Depreciation5.846.768.5510.0612.0613.2215.6426.9540.8171.99
Net Fixed Assets26.3128.6230.2734.6635.9644.76242.42250.85349.30275.31
CWIP 4.6627.2435.4919.6537.5400.070.0600
Investments 0000002.552.556.033.48
Inventories22.6027.3031.8133.3745.7157.1187.72121.13194.447.36
Trade Receivables53.1465.1068.7083.70106.54134.54169.88241.53332.90477.50
Cash Equivalents 2.095.792.682.3915.0820.7921.9523.705.513.26
Others Assets8.173.484.6418.5027.15112.7278.23201.94203.4016.85
Total Assets 116.97157.54173.57192.26267.98369.93602.83841.761,091.59783.76

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15
Cash Flow From Operating Activity -8.6310.0715.97-12.99-7.7312.106.9613.28-60.25-151.16
PBT 5.025.496.897.1715.2722.7737.2162.5586.39-325.28
Adjustment 6.268.189.1912.6116.1018.6327.6267.5686.31305.72
Changes in Working Capital -19.39-2.940.99-31.69-37.02-22.26-51.64-104.45-226.86-132.44
Tax Paid -0.52-0.67-1.09-1.08-2.08-7.04-6.24-12.38-6.100.84
Cash Flow From Investing Activity -6.90-26.50-11.578.18-21.11-61.87-158.13-123.49-21.29105.01
Capex -7.01-26.57-11.688.14-21.30-62.19-155.84-121.52-18.92111.76
Net Investments 000000-2.55000
Others 0.120.060.120.040.190.320.26-1.96-2.38-6.75
Cash Flow From Financing Activity 7.0120.14-7.524.5141.5455.48152.33111.9663.3643.90
Net Proceeds from Shares 000037.4112.600033.580
Net Proceeds from Borrowing -2.8229.08-4.860.582.8742.33124.9295.65-9.82-13.17
Interest Paid -4.54-6.49-7.47-11.93-13.90-16.62-22.10-58.41-66.72-77.17
Dividend Paid -0.39-1.24-1.26-1.30-1.02-1.50-3.90-3.78-6.39-5.66
Others 14.76-1.216.0717.1616.1818.6653.4178.50112.71139.90
Net Cash Flow -8.523.70-3.11-0.2912.695.711.161.75-18.19-2.25
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Jun'15
Ratios
ROE (%)8.1711.0211.9210.3620.1918.915.0926.5126.6N/A
ROCE (%)11.0810.8811.1713.1815.9814.9816.1820.2220.42N/A
Asset Turnover Ratio1.461.311.221.251.341.180.940.9810.84
PAT to CFO Conversion(x)-2.812.33.11-2.7-0.730.720.360.33-1.02N/A
Working Capital Days
Receivable Days108120121121112117122107108188
Inventory Days53515452475058546047
Payable Days41386156464739344424

Arvind Remedies Ltd Stock News

Arvind Remedies Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Arvind Remedies on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Arvind Remedies stood at ₹32.02.
The latest P/E ratio of Arvind Remedies as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Arvind Remedies as of 01-Jan-1970 05:30 is -0.20.
The 52-week high of Arvind Remedies is ₹4.70 and the 52-week low is ₹4.70.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Arvind Remedies is ₹12.21 ( Cr.) .

About Arvind Remedies Ltd

Arvind Remedies forayed into the world of quality healthcare in 1988 under the dynamic and ambitious stewardship of Arvind Shah, Managing Director and Chief Executive Officer.

The company was incorporated as a private limited company and started manufacturing and marketing of world-class allopathic and ayurvedic pharmaceutical products within and outside India, thus beginning to realise the vision of bringing high quality healthcare to the common man. Having grown notably in terms of production capacity, product categories, market share, advancements in R&D, market reach and global acceptance, the company is today a significant force to reckon with in the Indian pharmaceutical industry.

The company entered the field at a time when the Indian pharmaceutical industry was itself at the threshold of a new era, where product patenting and holistic healthcare were gaining prominence. The company’s core strength aptly lay in the ability to deliver both Western and Eastern varieties of quality treatments. Significant contributions have been made to the fields of cardiology, dermatology, nephrology and diabetes, among others. Having established its credibility as a company committed to providing world-class healthcare products, Arvind Remedies went public in April 1996 getting listed on the Bombay, Ahmedabad and Chennai Stock Exchanges. The public issue comprised of 30 lakh equity shares of Rs 10 each, at a premium of Rs 20 per share.

The company has also won international acceptance and recognition with exports to Africa, Commonwealth of Independent States and Asian countries.

Spread across 40,000 sq ft of own land, on which the built area is 30,000 sq ft, Arvind Remedies’ infrastructure and facilities are among the best and most modern in the world. ARL's state-of-the-art manufacturing facility and sophisticated research & development lab, located in the SIDCO Industrial area at Kakkalur, 45 km from Chennai, has been certified with GMP, under WHO norms. This factory manufactures pharmaceutical products in various dosages, like tablets, capsules, liquids, ointments, creams, suspensions, dry syrups, in addition to ayurvedic and herbal products.

Arvind Remedies has a sophisticated R&D lab well-equipped with instruments like HPLC, FTIR, UV Spectro Photo Meter, Dissolution Apparatus, Auto Titrator, Metler Balances, Digital DT Machine, etc. Focus areas are development of drug delivery systems, new formulations, process development of various dosage forms.

Products:

1. Allopathic

• Ethical Products  • Branded Generic Products • Generic Products

2. Ayurvedic

• Artin oil • Hygenex • Pankare • Pankare (Tab.) • Solufat • Sorexil • Stresof • Utritone

Clients:

• Defence establishments • ESI • CGHS • Central and state government institutions • Public sector companies • P&T • Railways, and • World Bank Projects.

Awards/ Recognition

  • 2010
    Arvind Remedies Ltd - Kakkalur, Thiruvallore manufacturing unit has been awarded Tamil Nadu Govt State Safety Award for the year 2010 from the Industrial Safety & Health, Tamil Nadu.
  • 2011-12
    Arvind Remedies Ltd has been awarded pioneers Award for Excellence in Healthcare 2012 from the Ministry of Health & Family Welfare in association with FICCI.
    Excellence Award received by Dr. B. Arvind Shah, MD and CEO from His Excellency the Governor of Tamil Nadu, V. Rosaiah for his contribution to the pharmaceutical industry for the year 2011-12.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.